Brijesh Anantharam
Overview
Explore the profile of Brijesh Anantharam including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
86
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gilpin T, Maznyczka A, Anantharam B, Dana A
Interv Cardiol
. 2024 May;
19:e05.
PMID: 38808283
Background: Chronic total occlusion (CTO) percutaneous coronary intervention (PCI) has evolved a great deal over recent years, with increased procedural success and lower complication rates being reported. This study aims...
2.
Kite T, Chase A, Owens C, Shaukat A, Mozid A, OKane P, et al.
J Invasive Cardiol
. 2024 Mar;
PMID: 38471155
Objectives: Cardiac surgery for coronary artery disease was dramatically reduced during the first wave of the COVID-19 pandemic. Many patients with disease ordinarily treated with coronary artery bypass grafting (CABG)...
3.
Birkhoelzer S, Cowan E, Anantharam B, Haworth P, Guha K, Hurst A, et al.
Clin Med (Lond)
. 2024 Jan;
23(Suppl 6):106.
PMID: 38182245
No abstract available.
4.
Kite T, Ladwiniec A, Greenwood J, Gale C, Anantharam B, More R, et al.
Heart
. 2023 Dec;
110(7):500-507.
PMID: 38103913
Objective: To investigate whether a very early invasive strategy (IS)±revascularisation improves clinical outcomes compared with standard care IS in higher risk patients with non-ST-elevation acute coronary syndrome (NSTE-ACS). Methods: Multicentre,...
5.
Mitropoulou P, Hobson A, Morton G, Anantharam B
Eur Heart J Case Rep
. 2022 May;
6(5):ytac184.
PMID: 35582544
Background: Duchenne's muscular dystrophy (DMD) is an X-linked muscular disease which is caused by the absence of dystrophin. This results in the death of muscle cells and cardiomyocytes and consequent...
6.
Kite T, Ladwiniec A, Owens C, Chase A, Shaukat A, Mozid A, et al.
Catheter Cardiovasc Interv
. 2021 May;
99(2):305-313.
PMID: 33942478
Objectives: To describe outcomes following percutaneous coronary intervention (PCI) in patients who would usually have undergone coronary artery bypass grafting (CABG). Background: In the United Kingdom, cardiac surgery for coronary...
7.
Seyani C, Anantharam B, Guha K
Br J Hosp Med (Lond)
. 2021 Apr;
82(4):1-3.
PMID: 33914623
No abstract available.
8.
Alaour B, Onwordi E, Khan A, Menexi C, Carta S, Strike P, et al.
Catheter Cardiovasc Interv
. 2021 Feb;
99(3):601-606.
PMID: 33576157
Objectives: To evaluate the outcome of unprotected left main stem (LMS) percutaneous coronary intervention (PCI) in a large UK nonsurgical center. Background: PCI on unprotected LMS is increasingly regarded as...
9.
Simard T, Jung R, Motazedian P, Di Santo P, Ramirez F, Russo J, et al.
Stem Cells Int
. 2017 Feb;
2017:8270498.
PMID: 28232850
Coronary revascularization remains the standard treatment for obstructive coronary artery disease and can be accomplished by either percutaneous coronary intervention (PCI) or coronary artery bypass graft surgery. Considerable advances have...
10.
Anantharam B, Janardhanan R, Hayat S, Senior R
Int J Cardiol
. 2013 Apr;
168(2):1670-1.
PMID: 23618431
No abstract available.